Archives
-
WSP-5 for Reproducible H2S Cell Assays
2026-10-01
WSP-5 (SKU C3378) is a turn-on fluorescent probe for sensitive, real-time monitoring of hydrogen sulfide in live-cell and disease-model assays. This scenario-based guide explains probe selection, preparation, controls, interpretation, and integration with viability or cytotoxicity workflows.
-
Tunable Human Intestinal Organoids for Cell-Fate Control
2026-09-30
The reference study develops a human small intestinal organoid system that maintains strong proliferation while expanding epithelial cell diversity under a unified culture strategy. Its central innovation is to strengthen stem-cell competence with small-molecule pathway modulation, then reversibly or directionally tune lineage outcomes through BET, Wnt, Notch, and BMP signaling.
-
One-step TUNEL Cy3 Kit for Apoptosis Mapping
2026-09-29
Learn how the One-step TUNEL Cy3 Apoptosis Detection Kit converts DNA fragmentation into a spatially resolved endpoint for oncology studies. This guide connects TdT-mediated labeling with mechanistic interpretation of AKT1-directed colorectal cancer research and practical assay design.
-
Procainamide Hydrochloride: A Translational Assay Map
2026-09-29
Procainamide Hydrochloride is more than a cardiac sodium channel blocker: it connects Nav1.5 electrophysiology with epigenetic, inflammatory, and chemoprotection assays. This guide translates key findings from a pregnant-mouse cisplatin study into practical experimental decisions.
-
Paroxetine Mesylate Research Workflows
2026-09-28
Build reproducible Paroxetine Mesylate workflows that connect SERT pharmacology with MET–ERBB3 pathway testing in colorectal cancer models. This guide combines dose-response design, mechanistic validation, 3D assays, polypharmacology controls, and troubleshooting for research use.
-
nPEC for Dual-Loaded Liposome Encapsulation Analysis
2026-09-28
A 2025 study compared six approaches for measuring encapsulation efficiency in liposomes carrying both hydrophilic and lipophilic drugs. Its results identify nanoparticle exclusion chromatography (nPEC), paired with HPLC analysis, as a practical, broadly applicable option for separating liposomes from free drug without pretreatment.
-
DNase I (GMP-grade): Scope and Workflow
2026-09-27
DNase I (GMP-grade), listed by APExBIO as SKU K1088R, is an enzyme product whose identity should not be confused with the circular RNA CAR-T therapy described in the cited study. The study reports preclinical results for DLL3-targeted circRNA CAR-T cells, but does not establish that K1088R was used or that DNase I itself contributes to CAR-T activity.
-
Partial BACE Inhibition Preserves Synaptic Transmission
2026-09-26
Satir et al. tested whether lowering amyloid-beta production through partial BACE inhibition could avoid disrupting synaptic activity. In cultured rat cortical neurons, reductions below 50% in secreted Aβ were not accompanied by detectable decreases in synaptic transmission, while stronger inhibition reduced transmission—supporting a dose-sensitive interpretation, not a general claim of clinical safety.
-
Sulfo-NHS-Biotin: Practical Protein Labeling
2026-09-25
Use Sulfo-NHS-Biotin for water-based amine labeling, including cell-surface tagging and affinity capture, with practical steps to protect sample function. A comparison with site-specific AviTag/BirA labeling helps you choose the right strategy when protein activity or antibody recognition is especially sensitive to modification.
-
Pentoxifylline Modulates Preterm Monocyte Inflammation
2026-09-25
Schüller et al. compared pentoxifylline effects on LPS-stimulated monocytes from preterm and term infants and adults, linking reduced inflammatory responses with lower TLR4 expression and signaling. The age-dependent findings highlight why neonatal immunomodulation should be evaluated in developmentally relevant models, while the in vitro design does not establish clinical benefit or effects on cell death.
-
HNRNPU K181 Lactylation Rewires Cervical Cancer Metabolism
2026-09-24
The study identifies HNRNPU K181 lactylation as a link between lactate accumulation, PHGDH expression, and serine metabolism in cervical cancer. Its findings point to a post-translational mechanism that stabilizes HNRNPU and supports tumor growth, while highlighting important questions about therapeutic specificity and transferability.
-
Prednisolone Workflows for Signaling Research
2026-09-24
Prednisolone supports controlled studies of glucocorticoid-receptor signaling, inflammation modulation, and cellular responses to corticosteroids. This guide pairs practical assay workflows with a clear distinction between receptor activation and the separate ERAD-hijacking strategy reported for transmembrane-protein degradation.
-
(S,S)-Nanaomycin A in NEPC Research
2026-09-24
Explore how (S,S)-Nanaomycin A can help test DNMT3B-dependent neuroendocrine lineage plasticity in prostate cancer models. This practical guide separates findings reported in the reference study from suggested pilot conditions, with workflows for cell-state profiling, viability, apoptosis, and follow-up validation.
-
PBS Liposomes for Rigorous Macrophage Controls
2026-09-23
PBS Liposomes provide a non-depleting comparator that helps distinguish liposome uptake and handling effects from clodronate-driven macrophage loss. This guide presents paired in vivo and ex vivo workflows, practical control logic, and troubleshooting strategies for more interpretable macrophage depletion experiments.
-
Antimycin A4: Designing Interpretable Metabolic Assays
2026-09-22
Antimycin A4 is an ATP-citrate lyase inhibitor with a second mitochondrial target that can complicate biological interpretation. This article presents an evidence-led framework for separating lipid-biosynthesis effects from respiratory-chain effects and translates a synthetic chemistry study into practical assay-design principles.